Goldman Sachs

Goldman Sachs’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Goldman Sachs’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,679,523	Closed	-$284K	–	5823
2024 Q2	$284K	Sell	1,679,523 -620,477	-27%	-$159K	﹤0.01%	5131
2024 Q1	$240K	Hold	2,300,000	–	–	﹤0.01%	5054
2023 Q4	$805K	Hold	2,300,000	–	–	﹤0.01%	4507
2023 Q3	$529K	Hold	2,300,000	–	–	﹤0.01%	4635
2023 Q2	$1.46M	Hold	2,300,000	–	–	﹤0.01%	4095
2023 Q1	$1.1M	Hold	2,300,000	–	–	﹤0.01%	4319
2022 Q4	$1.15M	Hold	2,300,000	–	–	﹤0.01%	4336
2022 Q3	$1.47M	Hold	2,300,000	–	–	﹤0.01%	4223
2022 Q2	$1.54M	Hold	2,300,000	–	–	﹤0.01%	4283
2022 Q1	$4.67M	Hold	2,300,000	–	–	﹤0.01%	3419
2021 Q4	$5.08M	Hold	2,300,000	–	–	﹤0.01%	3391
2021 Q3	$6.85M	Hold	2,300,000	–	–	﹤0.01%	3083
2021 Q2	$6.3M	Hold	2,300,000	–	–	﹤0.01%	3132
2021 Q1	$5.75M	Buy	2,300,000 +1,555,000	+209%	+$5.69M	﹤0.01%	3007
2020 Q4	$1.82M	Buy	+745,000	New	+$979K	﹤0.01%	3795

Other funds holding SRTAW

Walleye Capital

Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return